Navigation Links
FDA Approves PREZISTA®/ritonavir Once-Daily Dosing for HIV-1 Treatment-Experienced Adults With No Darunavir Resistance-Associated Mutations
Date:12/13/2010

TITUSVILLE, N.J., Dec. 13, 2010 /PRNewswire/ -- Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir resistance-associated mutations (DRV RAMs).(1)  

The revised dosing recommendation extends the same dosing already approved for treatment-naive patients – PREZISTA, co-administered with ritonavir (in combination with other antiretroviral agents and with food, once-daily (800/100 mg) – to treatment-experienced patients with no DRV RAMs. The previously approved dosing recommendation for PREZISTA/ritonavir in treatment-experienced patients (patients who have taken HIV medications in the past) was PREZISTA/ritonavir 600/100 mg twice daily.  

For antiretroviral treatment-experienced patients, genotypic testing is recommended. However, when genotypic testing is not feasible, PREZISTA/ritonavir 600/100 mg twice daily dosing is recommended.

The approval of this revision is based on 48-week data from the ODIN (Once-daily Darunavir In treatment-experieNced patients) study. ODIN evaluated the efficacy and safety of PREZISTA/ritonavir once daily vs. PREZISTA/ritonavir twice daily for the treatment of HIV-1 in treatment-experienced adult patients with no DRV RAMs (i.e., V11I, V32I, L33F, I47V, I50V, I54M, I54L, T74P, L76V, I84V, or L89V).

"With this once-daily dosing recommendation, boosted PREZISTA is now a viable option for more treatment-experienced patients," said Glenn Mattes, president, Tibotec Therapeutics. "This approval reflects Tibotec's ongoing commitment to optimizing dosing strategies for HIV patients."  

Data from the Phase 3b
'/>"/>

SOURCE Tibotec Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... ATLANTA , June 29, 2015  Alimera Sciences, ... that specializes in the research, development and commercialization of ... , Chief Operating Officer and Chief Financial Officer, will ... on July 8, 2015 at 8:00 a.m. ET at ... . The presentation will be webcast ...
(Date:6/29/2015)... , June 29, 2015 Regeneron ... that the Proceedings of the National Academy ... demonstrating that the Company,s proprietary VelociGene ® ... identification and preclinical validation of potential candidates that ... of Middle East Respiratory Syndrome (MERS). This involved ...
(Date:6/29/2015)... June 29, 2015  Arbor Solution has added ... The high-powered, multi-functional M2150 offers two ... Haswell Core i5-4402E 1.6 GHz processor and ... processing and computing performance. Integrated Intel® HD Graphics ... well suited for graphics-intense applications in operating rooms, ...
Breaking Medicine Technology:Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 2Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 3Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 4Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication 5Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 2Arbor Solution Introduces Multi-Function Medical Workstation with Large 21.5" True Flat Touch Screen 3
... TURKU, Finland, July 3 BioCis ... headquarters in Turku, Finland,announced positive results from its Phase ... topical drug for dermatology. This,double-blind, placebo-controlled study, conducted in ... who applied the ProtoCure,emulsion cream to the affected skin ...
... Tenn., July 2 Acura Pharmaceuticals, Inc. (Nasdaq: ... ) announced today that the U.S. Food and Drug Administration ... Drug Application (NDA) for Acurox (oxycodone HC1, USP and niacin, ... relief of moderate-to-severe pain. , , (Logo: ...
Cached Medicine Technology:BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 3
(Date:6/30/2015)... ... ... known as Body Brushing) is a wonderful daily practice all year round. In summer, ... the elements. , Dry Skin Brushing takes only 10 minutes per day, but delivers great ... on skin's surface. Skin is the largest organ of elimination and brushing helps the process. ...
(Date:6/30/2015)... ... June 30, 2015 , ... Some may define success as the ... efforts of New York State Athletic Trainers’ Association (NYSATA) and its members continue to ... two national awards, and a number of members also received honors at the national ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... to enhance successful student outcomes. According to Dr. Theo Wubbels (Professor of ... Teachers must be able to show “all kinds of behavior when the situation ...
(Date:6/30/2015)... ... June 30, 2015 , ... This Fourth of July, Peacock ... Alley story including hard work, tenacity, perseverance, commitment to quality, honesty and love of ... Born of Mary Ella Gabler's simple love of quilts, Peacock Alley was fully realized ...
(Date:6/29/2015)... ... June 30, 2015 , ... ... as a 2015-2016 inductee into its VIP Woman of the Year Circle. She ... nation’s leading networking organization exclusively for professional women, boasting more than 700,000 members ...
Breaking Medicine News(10 mins):Health News:Back in Stock: Keep Skin and Lymphatic System Healthy with Dry Skin Brushes from Sublime Beauty® 2Health News:NYSATA and Members Recognized with National Awards 2Health News:NYSATA and Members Recognized with National Awards 3Health News:Lessons On Leadership - Top 12 Global Teacher Bloggers Reveal the Best Strategies for Building Positive Leadership in Global Classrooms 2Health News:Luxury Linen Purveyor Peacock Alley Celebrates the Fourth of July 2Health News:National Association of Professional Women Inducts Melanie Richards, DMD, of Powdersville Pediatric Dentistry, Into its VIP Woman of the Year Circle 2
... hospital brings rehabilitation services to Mesa, BIRMINGHAM, ... ) today announced it has broken ground on ... inpatient,rehabilitation hospital will be located at 5652 E. ... Ariz., "We have been privileged to serve ...
... Tournament to be held at Woodmont,Country Club on Oct. ... Sandler,and his wife, Froma, are still dealing with the ... disease of unknown origin that has no,cure. Lisa died ... The Sandlers have turned their grief into action as ...
... cheering on driver Greg Biffle this weekend during round five ... Speedway in Concord,NC. Biffle, driver of the No. 16 3M ... points behind the leader., Biffle, along with the American ... Cross Racing during the April Talladega race to,educate NASCAR fans ...
... Monster.com and Eons.com founder Jeff Taylor and,futurist Leanne ... in,Philanthropy, SAN DIEGO, Oct. 9 The ... the Washington, D.C.-based independent accreditor that,offers more than ... care. Currently URAC accredits more than 400 health ...
... any assistance, MORAGA, Calif., Oct. 9 Despite ... it is regularly under diagnosed by,medical professionals., Most ... tension,headache, nausea, fatigue, or trembling -- before important events ... of stress such as a,divorce, job change or a ...
... treating vitamin D deficiency in children with cystic fibrosis (CF) ... at high risk for bone loss and rickets, according to ... results of their investigation, published in the October issue of ... found that nearly half of the 262 children with CF ...
Cached Medicine News:Health News:HealthSouth Announces Plans to Build New Hospital in Arizona 2Health News:HealthSouth Announces Plans to Build New Hospital in Arizona 3Health News:Parents Host Golf Tournament to Fund Cure for Disease That Claimed Daughter's Life 2Health News:Parents Host Golf Tournament to Fund Cure for Disease That Claimed Daughter's Life 3Health News:Red Cross Racing Members Cheer on Biffle in NASCAR Chase for the Sprint Cup 2Health News:Health Care Management Thought Leaders Converge for Summit on Cost, Quality and Consumer Focus 2Health News:40 Million Americans Endure Anxiety Everyday 2Health News:Children with cystic fibrosis not well covered by guidelines for vitamin D needs 2Health News:Children with cystic fibrosis not well covered by guidelines for vitamin D needs 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: